<DOC>
	<DOC>NCT00752219</DOC>
	<brief_summary>The purpose of this study is to determine whether NXL104 plus ceftazidime is effective in the treatment of complicated intra-abdominal infections as compared to a comparator group.</brief_summary>
	<brief_title>Prospective Multicenter Doubleblind Randomized Study of NXL104/Ceftazidime + Metronidazole vs. Meropenem in Treatment of Complicated Intra-abdominal Infections</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Intraabdominal Infections</mesh_term>
	<mesh_term>Avibactam</mesh_term>
	<mesh_term>Meropenem</mesh_term>
	<mesh_term>Thienamycins</mesh_term>
	<mesh_term>Ceftazidime</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<criteria>complicated intraabdominal infections infections limited to hollow viscus ischemic bowel disease without perforation acute suppurative cholangitis acute necrotizing pancreatitis pts to undergo stated abdominal repair, open abdomen technique or marsupialization Apache II &gt;25</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2009</verification_date>
</DOC>